Clinical Trials Update: Jan. 19, 2007
Endometriosis Acute Myelogenous Leukemia (AML) Non-Small Cell Lung Cancer
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will evaluate an investigational medication to manage endometriosis. Volunteers 18-46 who have been diagnosed with endometriosis by laparoscopy and have recurring pain associated with the condition may qualify.
The research site is in Tucson, Ariz.
Acute Myelogenous Leukemia (AML)
This study will evaluate the effectiveness of AZD1152 in people with acute myeloid leukaemia (AML) that has relapsed following an initial response to standard chemotherapy. Candidates 18 and older may be included who have AML in first relapse, relapse occurring between 3-12 months post completion of a full course of induction and consolidation chemotherapy (this can not include autologous and allogeneic stem cell transplantation), and who have not had radiotherapy, chemotherapy, or major surgery in the four weeks prior to study entry.
The research site is in Sherman Oaks, Calif.
Non-Small Cell Lung Cancer
This clinical study will assess if a new investigational drug is effective in treating non small cell lung cancer (NSCLC), when added to the chemotherapy agent Alimta. Patients at least 18 may be eligible who have been diagnosed with NSCLC, have been treated with only one course of therapy for lung cancer, have no previous treatment with Alimta, and have had no serious heart problems within the prior three months.
The research site is in Boston, Mass.
Copyright 2007 Thomson CenterWatch. All rights reserved.